Abstract:Abnormal DNA methylation is closely related to cancer initiation and progression, and strategies to assay methyltransferase activity and screen its inhibitors are essential for cancer diagnosis and therapy. In this work, surface plasmon resonance (SPR)-based assay for real-time and sensitive monitoring of DNA methyltransferase activity and screening of its inhibitors was conducted via methylation of double-stranded (ds)-DNA consensus sites and the follow-up p53 protein recognition. The consensus ds-DNA possesses a specific sequence of 5'-CCGG-3' in which the second C base can be methylated by M.SssI methyltransferase (M.SssI MTase) and the methylation process impedes the recognition and cleavage of the ds-DNA by HpaII endonuclease, thus, the attachment of p53 protein leads to remarkable SPR signals. In contrast, inhibition of M.SssI MTase activity by a potent inhibitor leaves the consensus ds-DNA unmethylated, and the cleavage of the ds-DNA by HpaII prevents p53 protein from adsorbing onto the chip surface, leading to tiny SPR signals. The binding affinity (K-D) between p53 protein and the methylated consensus ds-DNA was deduced to be 3.04 nM, evidencing the strong binding capability. Two nucleoside inhibitors of 5-Azacytidine (5-Aza) and 5-aza-2'-deoxycytidine (5-Aza-dC), and a non-nucleoside inhibitor of procaine were examined, and their half-maximal inhibiting concentration (IC50) values were highly comparable with those by other methods. The sensing protocol has been successfully utilized for the assay of M.SssI MTase activity in normal and cancer cell lysates. The proof-of-concept experiments demonstrate that SPR serves as a viable means for sensitive detection of methyltransferase activity and screening of its inhibitors using p53 protein bound to methylation-specific ds-DNA consensus sites.

The Establishment of a Screening Method of DNA Primase Inhibitors

Screening inhibitors for blocking UHRF1-methylated DNA interaction with capillary electrophoresis

Inhibition of Mitoxantrone on DNA Primase-Polymerase Α Complex Activity from Cancer Cells

Studies on N01WB-352A, B, the novel inosine 5′-monophosphate dehydrogenase inhibitors

A Surface Plasmon Resonance Biosensor Assay for Studying the Interaction Between Polymerase and DNA

A Novel Method for Efifcient Screening of Universal Primers

Development of A High-Throughput Screening Platform for Dna 3 '-Phosphatases and Their Inhibitors Based on A Universal Molecular Beacon and Quantitative Real-Time Pcr

Discovery of Novel Competitive Inhibitors of Eg5 by High Throughput Screening in Vitro

Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity

Screening the Active Constituents of Chinese Medicinal Herbs As Potent Inhibitors of Cdc25 Tyrosine Phosphatase, an Activator of the Mitosis-Inducing P34cdc2 Kinase

Screening of Antitumor Compounds from Natural Compounds or Its Derivatives by Using the Recombinant Human DNA Topoisomerase Ⅰ As Target

Microplate-based Method to Screen Inhibitors of Isozymes of Cyclic Nucleotide Phosphodiesterase Fused to SUMO

DNase-targeted natural product screening based on a sensitive and selective DNase I detecting system

A Chemical Probe Selectively Inhibits G9a and GLP Methyltransferase Activity in Cells

Establishment of a Screening Method for Mouse Reactive Suppressive Oligodeoxynucleotide in Vitro

Screening of Pim kinase inhibitors by the establishment of high-throughput ELISA system

Establishment of a Screening Protocol for Identification of Aminopeptidase N Inhibitors

Sensitive Surface Plasmon Resonance Detection of Methyltransferase Activity and Screening of Its Inhibitors Amplified by P53 Protein Bound to Methylation-Specific Ds-Dna Consensus Sites.

Synthesis and in Vitro Biological Evaluation of 3-Ethyl-1,5-naphthyridin-2(1h)-one Derivatives As Potent PARP-1 Selective Inhibitors and PARP-1 DNA Trappers

Stablizer Used in Inhibiting Residual Uracil DNA Glycosylase Activity in the PCR Products

Establishment,optimization and Application of a Screening Method for Immunoregulatory Oligodeoxynucleotides